Cardiovascular Revascularization Medicine
Volume 10, Issue 2 , Pages 103-109 , April 2009

Comparison of percutaneous coronary intervention in native coronary arteries vs. bypass grafts in patients with prior coronary artery bypass graft surgery

Received 22 August 2008 ,Revised 1 December 2008 ,Accepted 1 December 2008.

References 

  1. Goldman S, Zadina K, Moritz T, Ovitt T, Sethi G, Copeland JG, et al Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgery. Results from a Department of Veterans Affairs Cooperative Study. J Am Coll Cardiol. 2004;44(11):2149–2156
  2. Weintraub WS, Jones EL, Craver JM, Guyton RA. Frequency of repeat coronary bypass or coronary angioplasty after coronary artery bypass surgery using saphenous venous grafts. Am J Cardiol. 1994;73(2):103–112
  3. Fitzgibbon GM, Kafka HP, Leach AJ, Keon WJ, Hooper GD, Burton JR. Coronary bypass graft fate and patient outcome: angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years. J Am Coll Cardiol. 1996;28(3):616–626
  4. Morrison DA, Sethi G, Sacks J, Henderson WG, Grover F, Sedlis S, et al. Percutaneous coronary intervention versus repeat bypass surgery for patients with medically refractory myocardial ischemia: AWESOME randomized trial and registry experience with post-CABG patients. J Am Coll Cardiol. 2002;40(11):1951–1954
  5. Douglas J, Nguyen T, Cheem T. Approach to the patient with prior bypass surgery. In:  Nguyen T,  Hu D,  Saito S,  Grines C,  Palacios I editor. Advanced Interventional Cardiology. Blackwell Publishing Inc, Futura Division: New York; 2003;
  6. Chen L, Theroux P, Lesperance J, Shabani F, Thibault B, De Guise P. Angiographic features of vein grafts versus ungrafted coronary arteries in patients with unstable angina and previous bypass surgery. J Am Coll Cardiol. 1996;28(6):1493–1499
  7. Keeley EC, Velez CA, O'Neill WW, Safian RD. Long-term clinical outcome and predictors of major adverse cardiac events after percutaneous interventions on saphenous vein grafts. J Am Coll Cardiol. 2001;38(3):659–665
  8. Holmes DR, Berger PB. Percutaneous revascularization of occluded vein grafts: is it still a temptation to be resisted?. Circulation. 1999;99(1):8–11
  9. Preston LM, Calvin JE, Class S, Parrillo JE, Klein LW. Coronary angiographic morphology in unstable angina: comparative observations of culprit lesions in saphenous vein grafts versus native coronary arteries. J Invasive Cardiol. 2002;14(2):81–86
  10. Mehta SK, Frutkin AD, Milford-Beland S, Klein LW, Shaw RE, Weintraub WS, et al. Utilization of distal embolic protection in saphenous vein graft interventions (an analysis of 19,546 patients in the American College of Cardiology-National Cardiovascular Data Registry). Am J Cardiol. 2007;100(7):1114–1118
  11. Mathew V, Lennon RJ, Rihal CS, Bresnahan JF, Holmes DR. Applicability of distal protection for aortocoronary vein graft interventions in clinical practice. Catheter Cardiovasc Interv. 2004;63(2):148–151
  12. Mauri L, Cox D, Hermiller J, Massaro J, Wahr J, Tay SW, et al The PROXIMAL trial: proximal protection during saphenous vein graft intervention using the Proxis Embolic Protection System: a randomized, prospective, multicenter clinical trial. J Am Coll Cardiol. 2007;50(15):1442–1449
  13. Brilakis ES, Saeed B, Banerjee S. Use of drug-eluting stents in saphenous vein aortocoronary bypass graft lesions: a critical appraisal. J Interv Cardiol. 2008;21:151–157
  14. Vermeersch P, Agostoni P, Verheye S, Van den Heuvel P, Convens C, Bruining N, et al. Randomized double-blind comparison of sirolimus-eluting stent versus bare-metal stent implantation in diseased saphenous vein grafts: six-month angiographic, intravascular ultrasound, and clinical follow-up of the RRISC Trial. J Am Coll Cardiol. 2006;48(12):2423–2431
  15. Vermeersch P, Agostoni P, Verheye S, Van den Heuvel P, Convens C, Van den Branden F, et al. Increased late mortality after sirolimus-eluting stents versus bare-metal stents in diseased saphenous vein grafts: results from the randomized DELAYED RRISC Trial. J Am Coll Cardiol. 2007;50(3):261–267
  16. Brilakis ES, Lichtenwalter C, de Lemos JA, Roesle M, Obel O, Haagen D, et al A randomized-controlled trial of a paclitaxel-eluting stent vs. a similar bare metal stent in saphenous vein graft lesions. The SOS (Stenting Of Saphenous Vein Grafts) Trial. J Am Coll Cardiol. 2008;published online before print: http://content.onlinejacc.org/cgi/content/full/j.jacc.2008.11.029v1
  17. Brilakis ES, Berger PB. Should bare metal or drug-eluting stents be used during PCI of saphenous vein graft lesions: waiting for Godot?. Catheter Cardiovasc Interv. 2008;72:815–818
  18. Mehta RH, Honeycutt E, Peterson ED, Granger CB, Halabi AR, Shaw LK, et al. Impact of internal mammary artery conduit on long-term outcomes after percutaneous intervention of saphenous vein graft. Circulation. 2006;114(1 Suppl):I396–I401
  19. Kugelmass AD, Sadanandan S, Lakkis N, Dibattiste PM, Robertson DH, Demopoulos LA, et al. Early invasive strategy improves outcomes in patients with acute coronary syndrome with previous coronary artery bypass graft surgery: a report from TACTICS-TIMI 18. Crit Pathways Cardiol. 2006;(5):167–172
  20. Labinaz M, Kilaru R, Pieper K, Marso SP, Kitt MM, Simoons ML, et al. Outcomes of patients with acute coronary syndromes and prior coronary artery bypass grafting: results from the platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial. Circulation. 2002;105(3):322–327
  21. Servoss SJ, Wan Y, Snapinn SM, DiBattiste PM, Zhao XQ, Theroux P, et al. Tirofiban therapy for patients with acute coronary syndromes and prior coronary artery bypass grafting in the PRISM-PLUS trial. Am J Cardiol. 2004;93(7):843–847
  22. Ellis SG, Brener SJ, DeLuca S, Tuzcu EM, Raymond RE, Whitlow PL, et al. Late myocardial ischemic events after saphenous vein graft intervention—importance of initially “nonsignificant” vein graft lesions. Am J Cardiol. 1997;79(11):1460–1464
  23. Alderman EL, Kip KE, Whitlow PL, Bashore T, Fortin D, Bourassa MG, et al. Native coronary disease progression exceeds failed revascularization as cause of angina after five years in the Bypass Angioplasty Revascularization Investigation (BARI). J Am Coll Cardiol. 2004;44(4):766–774
  24. Boatman DM, Saeed B, Varghese I, Peters CT, Daye J, Haider A, et al. Prior coronary artery bypass graft surgery patients undergoing diagnostic coronary angiography have multiple uncontrolled coronary artery disease risk factors and high risk for cardiovascular events. Heart Vessels. 2008;[in press]

☆ Emmanouil S. Brilakis is supported by the Clark R. Gregg Fund, Harris Methodist Health Foundation, 6100 Western Place, Suite 1001, Fort Worth, TX 76107, USA, and by a Veterans Affairs VISN 17 startup award, Waco, TX, USA.

☆☆ Conflict of interest: Subhash Banerjee has received speaker hononaria from St Jude, Medtronic, and Johnson and Johnson, and a research grant from Boston Scientific. Emmanouil Brilakis has received speaker honoraria from St Jude.

PII: S1553-8389(08)00299-6

doi: 10.1016/j.carrev.2008.12.002

Cardiovascular Revascularization Medicine
Volume 10, Issue 2 , Pages 103-109 , April 2009

Article Tools

* Image Usage & Resolution